Fresh hope for cancer patients was delivered this month when it was announced that immunotherapy drug Keytruda received TGA approval for the treatment of 20 other cancers. Lifehouse recently ran a two-year trial with Keytruda, and was featured in a lot of the coverage about the announcement:
- Patient Paul Hazelwood featured heavily in the coverage. He spoke beautifully on how Keytruda changed his life and allowed him to live relatively normally with his wife and daughters despite having stage 4 small bowel cancer. You can read and watch his story in:
– The Sydney Morning Herald
– Northern Daily Leader
– The Transcontinental
– Nine News
– Seven News
- Dr Stephen Kao ran the initial 2-year trial here at Lifehouse and spoke to Nine News about how the genetic profile of a tumour is used to determine a patients’ suitability for the drug.
- Nine News, Channel 7 and Channel 10 all featured the news in their nightly bulletins on July 23rd.
Image credit: Illawarra Mercury, Robert Peet.